Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Completed · Phase 2
Conditions studied: Advanced Cutaneous Squamous Cell Carcinoma
In brief
The goals of this study are to evaluate the clinical benefit and safety of cemiplimab in participants with metastatic (nodal or distant) Cutaneous Squamous Cell Carcinoma (CSCC), or unresectable locally advanced CSCC.
Key facts
- Study ID
- NCT02760498
- Run by
- Regeneron Pharmaceuticals
- People needed
- 432
- Starts
- 2016-04-07
- Expected to finish
- 2023-10-18
- Last updated by the study team
- 2025-05-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic — Phoenix, Arizona, United States
- City of Hope Hospital — Duarte, California, United States
- University of California, Los Angeles — Los Angeles, California, United States
- Stanford University — Redwood City, California, United States
- University of California, San Diego — San Diego, California, United States
- University of Colorado, Denver — Aurora, Colorado, United States
- Mount Sinai Comprehensive Cancer Center — Miami Beach, Florida, United States
- H. Lee Moffitt Cancer Center — Tampa, Florida, United States
- Northwestern University — Chicago, Illinois, United States
- Norton Cancer Institute — Louisville, Kentucky, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
- Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
- St. Louis University — St Louis, Missouri, United States
- Washington University in St. Louis — St Louis, Missouri, United States
- Nebraska Methodist Hospital — Omaha, Nebraska, United States
- New York University — New York, New York, United States
- Memorial Sloan Kettering Cancer Center — New York, New York, United States
- University of Rochester Medical Center — Rochester, New York, United States
- Cleveland Clinic — Cleveland, Ohio, United States
- St. Luke's Hematology Oncology Specialists — Easton, Pennsylvania, United States
- Penn State Hershey Medical Center — Hershey, Pennsylvania, United States
- Dermatology and Laser Center of Charleston — Charleston, South Carolina, United States
- MD Anderson Cancer Center — Houston, Texas, United States
- University of Arizona Cancer Center — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.